Paola Rogliani to Middle Aged
This is a "connection" page, showing publications Paola Rogliani has written about Middle Aged.
Connection Strength
0.139
-
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? Expert Rev Respir Med. 2021 04; 15(4):561-568.
Score: 0.015
-
Are there pulmonary sequelae in patients recovering from COVID-19? Respir Res. 2020 Oct 30; 21(1):286.
Score: 0.015
-
Does bronchoscopy help the diagnosis in COVID-19 infection? Eur Respir J. 2020 08; 56(2).
Score: 0.014
-
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients. Neurol Sci. 2020 Oct; 41(10):2671-2674.
Score: 0.014
-
Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. Respir Res. 2018 04 12; 19(1):65.
Score: 0.012
-
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis. Pulm Pharmacol Ther. 2018 06; 50:28-37.
Score: 0.012
-
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study. Pulm Pharmacol Ther. 2018 04; 49:20-26.
Score: 0.012
-
Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort. J Cardiovasc Med (Hagerstown). 2021 03 01; 22(3):190-196.
Score: 0.004
-
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. Hum Genomics. 2020 09 11; 14(1):29.
Score: 0.004
-
HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020 11; 96(5):610-614.
Score: 0.004
-
COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells. Genes (Basel). 2020 08 27; 11(9).
Score: 0.004
-
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020 08; 88:11-16.
Score: 0.004
-
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1643-1646.
Score: 0.003
-
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone. Clin Respir J. 2019 Mar; 13(3):166-173.
Score: 0.003
-
Disease awareness in patients with COPD: measurement and extent. Int J Chron Obstruct Pulmon Dis. 2019; 14:1-11.
Score: 0.003
-
Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity. Lung. 2018 12; 196(6):707-713.
Score: 0.003
-
Associated Pulmonary Hypertension Is an Independent Contributor to Exercise Intolerance in Chronic Fibrosing Interstitial Pneumonias. Respiration. 2018; 96(6):543-551.
Score: 0.003
-
N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation. Biomed Pharmacother. 2018 Jul; 103:1-8.
Score: 0.003
-
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis. Respir Med. 2017 08; 129:189-198.
Score: 0.003
-
Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract. New Microbiol. 2017 Apr; 40(2):107-112.
Score: 0.003
-
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey. Pulm Pharmacol Ther. 2017 06; 44:83-87.
Score: 0.003